htasurv: a Stata module for performing survival analysis in economic evaluations

Jan 2, 2017

Written by David Trueman, Director

htasurv is an open source Stata module for assessing alternative parametric distributions when extrapolating survival data for use in health economic models. The function distfind loops through alternative distributions (specified by the user) and reports statistics and produces plots specified in NICE DSU TSD 14.0. The function distanalysis writes out results and useful statistics (e.g. the variance-covariance matrix) for the analyst. The module can be installed directly from github, using the github module. Once the github module is installed, installation of htasurv is:

github install sourceHEOR/htasurv

Syntax
For distfind:

distfind [varlist], dlist(string) timevar(varname) failure(varname) [GRaphs]

Where varlist are the variables in the survival model (often treatment), timevar is the variable defining the time-to-event, and failure is a binary variable for failure vs censoring (1=failure, 0=censored). If the graphs option is used, plots will be saved to curentdirectory/graphs. dlist is the list of distributions to estimate as lowercase strings (see example below). For distanalysis:

distanalysis [varlist], sdist(string) doctitle(string) [caption(string)] [fname(string)]

distanalysis will estimate the model with variables given in varlist with distribution given in sdist (full title; all lowercase). The resulting model will be written to .csv and .rtf files with file names given by doctitle. If a folder location is specified by fname, all files will be stored there (otherwise, the current directory is used).

Example use

sysuse cancer.dta, clear

global dlist “gamma weibull gompertz exponential lognormal loglogistic”

distfind age i.drug, dlist($dlist) timevar(studytime) failure(died)

distanalysis age i.drug, sdist(gompertz) doctitle(test) caption(“Gompertz”)

The software can be downloaded here. This software is released under the GNU General Public License version 3.

More Insights

Conceptual modelling and NICE requirements: a significant change or hill of beans?

Conceptual modelling and NICE requirements: a significant change or hill of beans?

Written by Alec Miners, Head of Health Economics The National Institute for Health and Care Excellence’s (NICE’s) new processes and methods guide includes several important changes to the way submitted economic evaluations should be conducted ... Read more

British Heart Week 2022

British Heart Week 2022

As we approach the end of British Heart Week, we reflect on some of the key stats around heart conditions in the UK and our contribution as a company to help bring cutting-edge treatments to patients with cardiovascular diseases Read more

Patient Participation Groups: A voice for patients for 50 years

Patient Participation Groups: A voice for patients for 50 years

Written by Dom Partridge, Medical Writer 6th to 13th June 2022 is Patient Participation Group (PPG) Awareness Week; aiming to raise the profile of PPGs within primary healthcare. The first Patient Participation Group The first PPG was set up in ... Read more

The Innovative Medicines Fund is now available to fast-track non-cancer medicines recommended with managed access

The Innovative Medicines Fund is now available to fast-track non-cancer medicines recommended with managed access

The Innovative Medicines Fund (IMF) launched this month (June 2022) to support faster access to non-cancer drugs. This process involves NHS England and the National Institute for Health and Care Excellence (NICE) working in partnership with ... Read more